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Skeletal muscle responds to endurance exercise with an
improvement of biochemical pathways that support sub-
strate supply and oxygen-dependent metabolism. This is
reflected by enhanced expression of associated factors
after exercise and is specifically modulated by tissue per-
fusion and oxygenation. We hypothesized that transcript
expression of pro-angiogenic factors (VEGF, tenascin-C,
Angpt1, Angpt1R) and oxygen metabolism (COX4I1,
COX4I2, HIF-1α) in human muscle after an endurance
stimulus depends on vasoconstriction, and would be
modulated through angiotensin-converting enzyme inhi-
bition by intake of lisinopril. Fourteen non-specifically
trained, male Caucasians subjects, carried out a single
bout of standardized one-legged bicycle exercise. Seven of
the participants consumed lisinopril in the 3 days before
exercise. Biopsies were collected pre- and 3 h post-
exercise from the m. vastus lateralis. COX4I1 (P = 0.03),
COX4I2 (P = 0.04) mRNA and HIF-1α (P = 0.05) mRNA
and protein levels (P = 0.01) showed an exercise-induced
increase in the group not consuming the ACE inhibitor.
Conversely, there was a specific exercise-induced increase
in VEGF transcript (P = 0.04) and protein levels
(P = 0.03) and a trend for increased tenascin-c transcript
levels (P = 0.09) for subjects consuming lisinopril. The
observations indicate that exercise-induced expression of
transcripts involved in angiogenesis and mitochondrial
energy metabolism are to some extent regulated via a
hypoxia-related ACE-dependent mechanism.
Exercise causes intensity-dependent vasodilation and
increases blood flow to contracting muscles (Andersen
& Saltin, 1985), ensuring an adequate oxygen supply
to the contracting muscle. This exercise hyperemia is
challenged by activation of sympatho-adrenergic and
nonadrenergic vasoconstrictor systems. After mild and
moderate intense exercise there is an exercise-induced
inhibition of AngII-induced vasoconstriction indicating
that muscle contractions attenuate adrenergic and non-
adrenergic vasoconstriction. During severe exercise
there is a higher sympathetic activity and an increase
in the activity of plasma renin and a subsequent
increase in the production of ACE and vasoconstrictor
angiotensin II (AngII) is observed (Staessen et al.,
1987). During increasing intensities of exercise, the
concomitant increasing activity in sympathetic vaso-
constrictor nerves is driven by a combination of
central nervous coactivation of motor control and sym-
pathetic outflow and muscle-derived afferents (Victor
et al., 1995).
There is evidence that the role of AngII in stimulating
angiogenesis relies on capillary perfusion of skeletal
muscle (Petersen & Greene, 2007). AngII elevates arte-
rial pressure because of its vasoconstrictor action and
restricts blood from entering non-active muscles in
order to direct blood flow to active tissues with
enhanced energy turnover (Andersen & Saltin, 1985).
The AngII-mediated vasoconstriction is overridden with
the onset of contraction through flow-mediated dilata-
tion of conduit arteries and arterioles and promotes
angiogenesis by activating the endothelial cell popula-
tion that constitutes the capillary wall (Hahn et al.,
1995; Brothers et al., 2006).
Training increases the capacity for aerobic adenosine
triphosphate production in skeletal muscle through an
elevation in the volume density of mitochondria in
untrained subjects (Hoppeler et al., 1985). After cycling
exercise under lowered ambient oxygen (hypoxia),
there is a larger increase in the volume density of
subsarcolemmal mitochondria compared with those
residing between myofibrils, indicating that local adap-
tations are specifically modified by the amount of
oxygen in the muscle during exercise (Desplanches
et al., 1993; Vogt et al., 2001; Schmutz et al., 2010). As
a result, there are improvements in maximal oxygen
uptake (VO2-peak), aerobic power, fatigue resistance,
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and also in subsarcolemmal mitochondria after training
in hypoxia compared with normoxia (Hoppeler &
Desplanches, 1992; Flück, 2006; Ponsot et al., 2006;
Zoll et al., 2006).
Metabolic and vascular adaptations that may be
involved in the hypoxia-specific improvement of
muscle-specific aerobic capacity after repeated endur-
ance workouts include the enzymes operating at critical
biochemical steps of mitochondrial respiration under
lowered muscle oxygenation during severe exercise in
hypoxia (Richardson et al., 1995; Flueck, 2009). One of
the key metabolic enzymes is cytochrome c oxidase,
which is the last enzyme in the respiratory electron trans-
port chain converting molecular oxygen to water. After
one bout of intense bicycle exercise under hypoxia,
increased expression of isoforms 1 and 2 of oxygen-
sensitive cytochrome c oxidase (COX4I1, COX4I2)
plays a role in the enhancements of the aerobic capacity
(Flueck, 2009, 2010; Desplanches et al., 2014). After
exhaustive endurance exercise in hypoxia, the expression
of COX4I2 is elevated more than the isoform COX4I1
(Fukuda et al., 2007). A correlation between elevated
COX4I2 transcripts post-exercise and the increased
volume density of subsarcolemmal mitochondria after
30 repetitions of the exercise stimulus with training sup-
ports that transcript expression post-exercise reflects
exercise-induced mitochondrial plasticity (Desplanches
et al., 2014).
Another important factor, vascular endothelial growth
factor (VEGF), causes increases in vascular permeabil-
ity, endothelial cell proliferation, and angiogenesis.
Breen et al. (1996) showed that mRNA levels of angio-
genic growth factors such as VEGF in the gastrocnemius
of rat were significantly increased after a bout of endur-
ance exercise. The same was found after a period with
chronic electrical stimulation during exercise (Hang
et al., 1995) indicating that muscle activity leads to an
increase in mRNA levels for angiogenic growth factors.
The findings support the notion that transcript level
alterations in skeletal muscle after a single bout of endur-
ance exercise are a proxy for the subsequent adaptations
with repetition of an endurance stimulus (Flück, 2006;
Desplanches et al., 2014).
Muscle transcript expression after endurance exercise
is graded with regard to metabolic stress and modulated
by oxygenation (Schmutz et al., 2010). We hypothesized
that the exercise-induced alteration in expression of
genes of pro-angiogenic and oxygen-dependent factors
are modulated by ACE activity because of its influence
on muscle perfusion (Brothers et al., 2006). We hypoth-
esized that pro-angiogenic factors such as VEGF,
tenascin-C, Angpt1, and Angpt1R are increased post-
exercise while oxygen-dependent factors such as
COX4I, COX4I2, and HIF-1a are blunted after exercise
in subjects taking an ACE inhibitor. This was tested in
biopsies of knee extensor muscle within 3 h after a single
bout of bicycle exercise.
Materials and methods
Experimental design
The study has been approved by the ethics board of the Man-
chester Metropolitan University. Written informed consent was
obtained from every participant. To test our hypothesis, we carried
out a pharmacological intervention with humans that were char-
acterized anthropometrically. Fourteen Caucasian male subjects,
non-specifically trained, took part in the study carrying out a
maximal exercise test to characterize aerobic fitness and the
muscle response to a single bout of one-legged exercise where we
collected muscle and blood samples (Table 1).
Anthropometric and functional characterization
In an entry test, peak aerobic power and VO2-peak were estab-
lished with a maximal exercise test and subject’s height and mass
were measured. Blood pressure was measured in a calm place in
seated position with a sphygmomanometer after the subject has
been sitting for at least 15 min. Seven of the participants were
asked to consume daily an ACE inhibitor (ACE inhibition group:
lisinopril, 10 mg/day, Zestril, AstraZeneca, London, United
Kingdom) in the morning for 3 days including the day of the
exercise test, the other group (control group) was not asked to use
the ACE inhibitor. On the testing day, subjects reported fasted to
the laboratory and performed a single-leg standardized exercise
test within 5 h after the last medication was consumed. Venous
blood and a biopsy sample from vastus lateralis muscle were
collected by a physician (S. W.). Blood collection was done via
venipuncture from the upper arm before and immediately after the
bout of exercise, while the subjects were in a sitting position. 5 mL
of blood was drawn from the cephalic vein into a tube sprayed with
dry EDTA (K2E BD Vacutainer, Belliver Industrial Estate, Plym-
outh, UK) placed on ice. A 2-mL aliquot was rapidly processed for
the measure of AngII.
Biopsies were collected under local anesthesia (subcutaneous
injection of 1 mL 2% lidocaine) before and 3 h post-exercise from
the belly portion of vastus lateralis muscle with a needle device
(TSK Acecut 11G, UK biopsy).
Table 1. Participants details
ACE inhibition
group
Control
group
Age (years) 30.3 ± 2.7 23.3 ± 1.3
Height (m) 1.76 ± 0.04 1.80 ± 0.02
Mass (kg) 75.4 ± 4.6 72.3 ± 2.9
Exercise (h/week) 10.4 ± 1.8 3.2 ± 0.6
Before ACE inhibition
Blood pressure (bp)
Systolic bp (mm Hg) 130.8 ± 7.1 118.9 ± 1.8
Diastolic bp (mm Hg) 71.4 ± 4.1 71.4 ± 1.7
VO2-peak two-legged (L/min) 3.72 ± 0.74 3.65 ± 0.32
Peak aerobic power two-leg
(watt)
320.0 ± 23.5 281.0 ± 22.8
After ACE inhibition
Systolic bp (mm Hg) 129.8 ± 4.1
Diastolic (mm Hg) 69.6 ± 3.5
VO2-peak one-leg (L/min) 3.3 ± 0.2 3.2 ± 0.6
Peak aerobic power one-leg
(Watt)
174.3 ± 10.9 177.0 ± 13.1
VO2-peak one-leg vs two-leg 0.90 ± 0.02 0.86 ± 0.05
Peak aerobic power one-leg vs
two-leg
0.55 ± 0.01 0.63 ± 0.02*
Values refer to mean ± SE.
*P < 0.05 for group difference (unpaired t-tests).
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Maximal exercise test
Two-leg exercise aerobic capacity was measured before the one-
legged test with ergospirometry during a cycling exercise test on
an Excalibur bicycle (Lode, Groningen, the Netherlands). Expired
air was measured breath by breath (Oxycon alpha, Jager GmbH,
Wurzburg, Germany) and heart rate using a heart rate belt
(Accurex Plus, Polar Electro Finland, Kempele, Finland). The test
started at 40 W and subjects were asked to cycle at 80 revolutions
per minute (rpm). The power was increased every 2 min with
30 W until the subject could no longer maintain a cadence higher
than 60 rpm with verbal support.
One-legged exercise test
Subjects completed the one-leg exercise test with their dominant
leg and the shoe taped with duct tape to the pedal on an Excalibur
bicycle (Lode). The protocol of the exercise test was a 3-min
warm-up at 50 W, followed by 25 min at 1.2-times body mass in
watts and ending with a ramp up of 10 W/min until exhaustion (see
Fig. 1 for the characteristics of the stimulus). The subjects cycled
at a cadence of 80 rpm and the test ended when in the last phase
the cadence dropped below 60 rpm. This protocol was chosen to
maximize the metabolic stimulus for recruited muscle groups,
without central aspects posed a limitation that may interact with
the systemic effects of ACE activity on blood pressure and
perfusion.
Assessment of AngII levels
Blood (2 mL) was withdrawn from the venous cannula into
vacutainers containing 60 μL AngII inhibitor cocktail, comprising
13.35 μL of O-phenanthroline and pepstatin A in DMSO mixed
with 46.65 μL of EDTA and PHMB in aqueous solution (SPI Bio,
Bertin Pharma, Versailles, France). The samples were immediately
centrifuged at 10 000 rpm (3000 g) and 4 °C for 12 min. The
supernatant was separated, snap frozen in liquid nitrogen, and
stored at −80 °C until analyzed. Plasma was extracted with C18
phenyl cartridge which were conditioned with 2 mL of methanol
and then rinsed with 2 mL of water. Cold plasma (0.9 mL) was
rapidly passed through the cartridge and subsequently washed
with 1 mL of water. Absorbed angiotensins were eluted with 1 mL
of methanol into conical polypropylene tubes. The eluate was
evaporated to dryness by means of a nitrogen gas stream at room
temperature and the residue was stored at −20 °C. AngII was
assessed with the AngII enzyme immunoassay kit (Spi Bio,
Montigny Le Bretonneux, France). Briefly, the plasma samples
were incubated for 1 h with 100 μL of EIA buffer (reconstituted
the EIA buffer vial with 50 mL of distilled water), for 5 min with
50 μL of glutaraldehyde (100 μL of glutaraldehyde diluted in
0.125 mL of concentrated wash buffer and 4.878 mL of distilled
water), for 5 min with 100 μL of borane-trimethylamine (borane-
trimethylamine vial diluted in 2.5 mL of 2N HCL and 2.5 mL of
methanol) on a rocker platform, and with 100 μL of anti-AngII
IgG tracer (reconstituted the anti-angiotensin II-IgG tracer in
10 mL of EIA buffer) at 4 °C overnight. On the next day, the
samples were incubated with 200 μL of Ellman’s reagent
(Ellman’s reagent vial in 1 mL of concentrated wash buffer and
29 mL of distilled water). The plate was run with a single quick
read on an Absorbance Microplate Reader (ELx800, BIO-TEK,
Swindon, UK) with wavelength 405 after 30 min, 1 h, and 2 h of
incubation.
After plotting the absorbance of each standard point vs the
concentration, the AngII concentrations were calculated by inter-
polating from this standard curve. In order to reduce variability,
AngII values were normalized to the median of the pre- values.
Transcript measures
Total RNA was isolated from 10 mm3 of biopsy samples in 20 μm
sections using an RNeasy mini kit (Qiagen, cat no. 74101, Venlo,
the Netherlands) and Proteinase K (Qiagen, cat no. 19131) as
described by Schmutz et al. (2010). Concentration and quality of
RNA were determined using a NanoDrop USV-99 AGTGene
(Labgene Scientific SA, Switzerland).
cDNA was reverse transcribed from 600 ng of RNA using
a OMNIscpript Kit (Qiagen, cat no. 205110) with random
hexameres according to the manufactures’ instructions. RT-qPCR
was carried out for eight candidate genes (tenascin-C, COX4I1,
COX4I2, HIF-1a, VEGF, AngPt1, AngPt1receptor, and GAPDH)
and the reference gene for normalization (28S r RNA). cDNA
corresponding to an estimated input of 6 ng (0.6 ng for 28 s) was
dispensed into each well with a final reaction volume of 10 μL.
Pooled primer pairs (200 nM each) and KAPAS Sybr FAST
Master MIX 2X (Kapa Biosystems, KK4600, London, UK) were
performed on Eco™ Thermal and Optical system (Illumina,
Labgene Scientific SA). Primer sequences for each gene are listed
in Table 2. Each sample was amplified in duplicate using the
following conditions: preheating at 95 °C for 2 min, followed by
45 cycles at 95 °C for 15 s and 60 °C for 1 min. The calculation of
Fig. 1. The characteristics of the stimulus of the single-leg exercise test. Line graph showing the imposed performance (thick
rectangular line) and oxygen uptake (thinner ragged line) of one subject over time.
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transcript amounts were analyzed with the ΔCT method but taking
the individual efficiency into account. The resulting values were
standardized to those of 28S.
Protein biochemistry
Total protein homogenate was prepared from muscle biopsies. In
brief, 25 μm cryosections were prepared from an estimated
volume of 5 mm3, pooled and homogenized in ice-cold 0.1 M
KH2PO4 buffer including inhibitor (Complete-mini EDTA-Free
reagent, Roche Diagnostics GmbH, Mannheim, Germany) using a
Polytron®PT 1200E hand-held homogenizer (Kinematica AG,
Lucerne, Switzerland). Protein concentration of the total homog-
enate was determined using the BCA method (Pierce, Rockford,
Illinois, USA). 7 μg of total protein from pre-/post-sample pairs in
Laemmli buffer (Bio-Rad Laboratories AG, Cressier, Switzerland)
and 2% mercaptoethanol were denatured and separated by 7.5%
SDS-PAGE using precast gels (Bio-Rad Mini-protean TGX
Stain-free). Proteins were blotted onto a nitrocellulose membrane
with a Trans-blot-Turbo Transfer System (Bio-Rad), stained with
Ponceau S to record protein loading based on the staining of actin
and subjected to immunodetection with specific primary (VEGF:
monoclonal antibody 26503 (Abcam, Cambridge, UK); HIF-1α:
monoclonal antibody GR218993 (Sigma-Aldrich Chemie AG,
Buchs, Switzerland) and horse-radish peroxidase-conjugated sec-
ondary antibody in 5% milk/1% BSA – TTBS (20 mM Tris-base,
150 mM NaCl, 0.05% Tween-20, pH 7.6). Signal was recorded
with enhanced chemoluminescence (Supersignal West Femto,
Thermo Scientific, Hudson, NH, USA) using a PXi System
(Syngene, Cambridge, UK).
Statistics
Data were organized in MS-Excel and exported into SPSS 19.0
(SPSS Inc., Chicago, Illinois, USA) for statistical testing. Differ-
ences in blood pressure and AngII were analyzed with a paired
samples t-test. Pre-/post-changes and fold changes in transcript
and protein expression between the ACE inhibition group and
control group were assessed with a multiple analysis of variance
(ANOVA) and a two-factor ANOVA, respectively. Significance of
a difference was declared at P < 0.05.
Results
Anthropometry (mass, height, age), VO2-peak, peak
aerobic power and resting blood pressure of the subjects
of the two groups did not differ significantly (Table 1).
There was no difference in systolic (P = 0.16) or dia-
stolic blood pressure (P = 0.94) between the study
groups. Intake of ACE inhibitor did not affect systolic
(P = 0.90) or diastolic (P = 0.73) blood pressure at rest
(Table 1). The ratio for peak aerobic power between the
one- and two-legged VO2max tests was lower for the
lisinopril than the control group.
There was a trend for an effect for the intake of ACE
inhibitor on the fold changes in expression of all tran-
scripts combined post-exercise (P = 0.09; Fig. 2). Fold
changes in transcript expression in the vastii was signifi-
cantly higher 3 h post-exercise in the control group for
COX4I2 (P = 0.03) and HIF-1α (P = 0.05). The level of
COX4I2 was increased 3 h post-exercise in the control
group (P = 0.04) but not in the ACE inhibition group
(P = 0.91).
Fold changes in transcript expression post-exercise
was significantly larger in the absence of ACE inhibitor
intake of the pro-angiogenic transcript VEGF (P = 0.04).
A trend for such an effect was seen for tenascin-c
(P = 0.09).
The protein level of HIF-1α and VEGF, which tran-
scripts were affected by ACE post-exercise were mea-
sured. HIF-1α protein was specifically increased 3 h
after one-legged exercise in the group that did not
consume lisinopril (Fig. 3). Conversely, VEGF protein
was selectively increased 3 h after one-legged exercise in
the group that did consume lisinopril.
AngII levels were 1.6 times and glucose 1.2 times
increased after exercise under oral intake of ACE
without significant increases in the control group (see
Table 3).
Discussion
Three hours after exhaustive cycling exercise the pro-
angiogenic factor VEGF and tenascin-C were increased
in the ACE inhibition group, but not in the control group.
This observation contrast to the results of Gavin
et al. (2000b), which demonstrated that VEGF mRNA
expression increased after an hour of moderate intense
exercise (≈ 50% VO2max) irrespective of whether the first-
generation ACE inhibitor captopril was administered or
not.
Table 2. Summary of the primers sequence for the selected gene
transcripts
Primer Sequences
28S rRNA Forward primer: 5'ATA TCC GCA GCA GGT CTC CAA-3'
Reverse primer: 5'-GAG CCA ATC CTT ATC CCG
AAG-3'
Angpt1 Forward primer: 5'-CGC TGC CAT TCT GAC TCA CAT
A-3'
Reverse primer: 5'-CGG TTA TAT CTT CTC CCA CTG
TTT TC-3'
Angpt1R Forward primer: 5'- GTT GGC CTT TCT GAT CAT ATT
GC-3'
Reverse primer: 5'-GGT TCT TCC CTC ACG TTT TGG-3'
COX-1 Forward primer: 5'-CTA TAC CTA TTA TTC GGC GCA
TGA-3'
Reverse primer: 5'-CAG CTC GGC TCG AAT AAG GA-3'
COX-4I1 Forward primer: 5'-GCC ATG TTC TTC TTC ATC GGT
TTC-3'
Reverse primer: 5'-GGC CGT ACA CAT AGT GCT TCT
G-3'
GAPDH Forward primer: 5'-GGA GCG AGA CCC CAC TAA CA-3'
Reverse primer: 5'-GCC TTC TCC ATG GTG GTG AA-3'
HIF-1α Forward primer: 5'-TAG TGA ACA GAA TGG AAT GGA
GCA A-3'
Reverse primer: 5'-TTT TTG GAC ACT GGT GGC TC-3'
Tenascin-C Forward primer: 5'-ACCTCTCTGGAATTGCTCCCA-3
Reverse primer: 5'-CATCTGAAACTAGAAGGTTGTC-3'
VEGF Forward primer: 5'-CAT GGC AGA AGG AGG AGG GCA
GAA TCA-3'
Reverse primer: 5'-ATC TTC AAG CCA TCC TGT GTG
CCC CTG-3'
Angpt, angiopoetin; Bp, base par; COX, cytochrome C oxidase; GPDH,
glyceraldehydes-3-phosphate dehydrogenase; HIF-1α, hypoxia-inducible
factor-1a; PCR, polymerase chain reaction; VEGF, vascular endothelial
growth factor.
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Flueck (2009) reviewed that endurance training under
hypoxia enhances the structural components of local
aerobic capacity by increasing mitochondrial protein
expression. The low intramuscular oxygen levels in the
muscle in combination with contraction-related signals
are the driving force for angiogenic and mitochondrial
protein expression with endurance training. Involvement
of signaling to muscle remodeling with low oxygen
content with exercise is illustrated by the modulation of
the master regulator of hypoxia-regulated gene expres-
sion, the dimeric transcription factor HIF-1 (Semenza,
2004). Hypoxia-dependent regulation by HIF-1 is turned
off in well-oxygenated conditions by the degradation of
its alpha-subunit, HIF-1α. When the hypoxia drops to a
critical level, HIF-1α is stabilized (Flueck, 2009). In our
study, we identified that HIF-1α transcript levels were
more increased in the control than the lisinopril group
(Fig. 3). HIF-1α has been shown to increase after 45 min
of one-legged knee-extension exercise until 6 h into
recovery (Ameln et al., 2005). Our present novel evi-
dence for the enhanced stabilization of HIF-1α in the
absence of lisinopril, are in line with the former results
and suggests that muscle oxygenation was more reduced
in knee extensor muscle of subjects that performed the
exhaustive one-legged exercise in the absence of
lisinopril.
Similarly, we found that HIF-1α transcript levels were
increased in the control group, while they were blunted
in the ACE inhibition group. The same was observed for
COX4I2. We have reported before that HIF-1α and
COX4I2 transcript levels are regulated in a hypoxia-
modulated manner after two-legged endurance type
bicycle exercise (Desplanches et al., 2014). Thereby,
COX4I2 transcript levels were increased 24 h after a
single exercise bout at 65% of respective peak aerobic
power output in ambient hypoxia equivalent to 4000 m
above sea level. Exercise in hypoxia produces a pro-
nounced drop in muscle oxygenation (reviewed in
Desplanches et al., 2014). This emphasizes that
enhanced COX4I2 mRNA expression in exercised
muscle constitutes a marker of local hypoxia (Fukuda
et al., 2007). These considerations support the notion
based on the measure of HIF-1α protein that ACE
inhibitor-induced modulation of COX4I2 and HIF-1α
transcript levels in m. vastus lateralis after exhaustive
endurance exercise is related to muscle oxygenation
Fig. 2. Transcript expression in the vastus muscle 3 h post-exercise with or without intake of ACE inhibitor. Bar graph of the
mean + SE fold changes of selected gene transcript 3 h after the single-leg exercise. AngPt1, angiopoietin 1; COX4I1, isoform 1 for
subunit 4 of cytochrome c oxidase; COX4I2, isoform 2 for subunit 4 of cytochrome c oxidase; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; HIF-1α, hypoxia-inducible factor α-subunit; VEGF, vascular endothelial growth factor. * and † denote significant
difference (P < 0.05 ) and trend (0.05 ≤ P < 0.10) between fold changes in the group under ACE inhibition and the control group
(repeated measures ANOVA).
Table 3. AngII and glucose levels with endurance exercise and the effect of ACE inhibition
Group Pre Post Fold
AngII (pg/mol) ACE inhibition 17.4 ± 3.7 25.0 ± 3.9† 1.6 ± 0.4*
Control 15.2 ± 4.1 19.4 ± 2.6 1.8 ± 0.6
Glucose (mmol/L) ACE inhibition 2.3 ± 0.1 2.9 ± 0.2† 1.2 ± 0.5*
Control 4.7 ± 0.5 4.6 ± 0.8 1.0 ± 0.2
Values are mean ± SEM paired samples t-test.
*Denotes P < 0.05 vs pre- values.
†Denotes P < 0.05 for post-exercise values vs the control group.
Lisinopril affects muscle response to exercise
5
during exercise. Our observations also imply that the
ACE-modulated response of VEGF transcript and
HIF-1α protein 3 h after one-legged exercise did not
correspond (compare Figs 2 and 3). Expression of the
VEGF transcript after acute hypoxia in isolated cells or
chronic hypoxia in the heart (Semenza et al., 1999;
Semenza, 2004) has been described to depend on HIF-
1α. Under the given situation of a single measure post-
exercise, it is difficult to reconcile these data with our
observations. However, VEGF protein expression has
been described to increase in association with muscle
capillaries with enhanced contractile muscle activity
(Hudlicka & Brown, 2009) while HIF-1a protein has
been demonstrated to increase in nuclei and cytoplasm
of muscle fibers (Ameln et al., 2005). Our data therefore
indicate the possibility that differences in the oxygen-
ation of cells involved in oxygen delivery (endothelium)
and consumption (muscle fibers), and the time course of
response, may provide a possible explanation for the
observed difference between HIF-1α and VEGF tran-
script and protein expression post-exercise.
The AngII values were 1.6 times higher after exercise
in the ACE inhibition group and not significantly
increased in the control group. This increase in AngII is
comparable with the study of Fagard et al. (1985) that
demonstrated an intensity-dependent increase in angio-
tensin 2 after exhaustive bicycle type exercise. The
increase in the ACE inhibition group, as well as the
higher increase in this group compared with the control
group, could indicate an incomplete inhibition of ACE
during and after exercise. The difference in AngII levels
between the two groups can possibly be explained by an
efficient ACE inhibition at rest, reducing AngII levels to
lower levels, so to allow an increase post-exercise under
a possibly incomplete ACE inhibition during exercise.
This is supported by the study of Aldigier et al. (1993)
that found a higher increase of AngII in the ACE inhibi-
tion group during exercise compared with the control
group.
We also observed a group difference in the ratio of
peak aerobic power between one- and two-legged VO2max
tests, i.e., 0.55 vs 0.63. This ratio can be considered to
reflect how peak aerobic capacity of the peripheral leg
muscles can be met by the cardiovascular supply of
oxygen during maximal whole-body exercise (McPhee
et al., 2010). While we cannot exclude that individual
differences existed in muscle perfusion between the two
groups, the relatively similar and high VO2-peak 1 vs
2-leg ratios (i.e., 0.90 and 0.86) do not support this
possibility. In consequence, we suggest that our obser-
vations provide evidence for a negative impact of short
duration ACE inhibition on muscle performance.
The data in the present study point at an effect of
commonly used anti-hypertensive treatment on the
muscle response to exhaustive bicycle type endurance
exercise. This supports the view that an angiotensin-
regulated mechanism dictates the hypoxia-specific gene
response in peripheral muscle to endurance exercise.
Gavin et al. (2000b) have previously identified that
captopril reduces mRNA of the VEGF receptor Flk-1 by
30–40% in skeletal muscle independent of exercise in rat
gastrocnemius muscle but did not find effects on
angiogenesis-associated VEGF, VEGF receptor (Flt-1),
TGF-beta(1), bFGF, and Flk-1 mRNA when assessed
approximately 1 h after a one 1-h running stimulus and
anaesthesia under breathing of 100% oxygen. Our find-
ings show that the second generation ACE inhibitor
lisinopril increases pro-angiogenic factors associated
with the capillaries in the interstitium, i.e., VEGF and
tenascin-C (Flück et al., 2000; Milkiewicz et al., 2001)
and inhibits the increase in oxygen-dependent tran-
scripts, which are thought to mainly situate in muscle
fibers (COX4I2, HIF-1α). A number of factors, which
Fig. 3. HIF-1α and VEGF protein expression in function of
lisinopril intake.
(a) Representative immunoblots of HIF-1α and VEGF protein
pre- and 3 h post-single-leg exercise in one subject that con-
sumed lisinopril and in a control subject. (b) Bar graph of
mean + SE of fold changes in HIF-1α and VEGF protein with
exercise. #P < 0.05 post- vs pre-exercise. *P < 0.05 for fold dif-
ferences post- vs pre-exercise between groups (repeated).
ANOVA with post-hoc test of Fisher.
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we cannot evaluate potentially, explain this difference.
Differences in study design aside, this includes pro-
nounced differences between the pharmacodynamics of
the second- and first-generation ACE inhibitors lisinopril
and captopril. For instance, short- and long-lived actions
of lisinopril and captopril (Giles et al., 1989), respec-
tively, likely will have added to the dissimilarity in appli-
cation of captopril in the rat [20 min (Gavin et al.,
2000a)] and lisinopril (3 days) in our human investiga-
tion. Lastly, the time point of measure, i.e., 1 vs 3 h after
exercise, the selected transcripts, inter-species, and ana-
tomical differences in the studied muscles may account
for the discrepancy as well.
The dichotomy between transcript regulations was
mirrored by the influence of lisinopril on the exercise-
induced changes in VEGF and HIF-1α protein expres-
sion (Fig. 3). Our previous studies in HIF-1α-deficient
transgenic mice showed that HIF-1α is involved in the
up-regulation of mitochondrial gene transcripts in skel-
etal muscle at rest in response to the acute stimulus of
severe hypoxia (Däpp et al., 2006). Consequently, we
interpret the up-regulation of HIF-1α protein, HIF-1α
transcripts, and mitochondrial transcripts post-exercise
in subjects, which did not consume lisinopril, as evi-
dence for hypoxia-related mitochondrial biogenesis.
Conversely, we interpret the increase in VEGF mRNA
and protein post-exercise in the subjects, which con-
sumed lisinopril, to reflect a response of the capillary
endothelium in exercising muscle with their assumed
increased perfusion, and shear stress (Hudlicka &
Brown), caused by the reduced vasoconstriction with
lisinopril intake. Overall, our findings indicate that there
is a shift in the activation of the gene program from
muscle fibers to the surrounding interstitium under oral
intake of ACE inhibitor. As ACE inhibitors in combina-
tion with endurance type of exercise are both widely
prescribed for subjects with hypertension, our findings
can have ramifications for improving the current anti-
hypertensive treatment.
A limitation of this study is that it is not built on a
cross-over design and the absence of further time-points
of biopsy sampling. Both shortcomings are explained by
ethical restrictions imposed for the collection of muscle
material from volunteers. The absence calls for a further
study to confirm our findings and expose the functional
implication of our observation. As this study is based
upon a single exercise bout, the protein levels corre-
sponding to the measured transcripts (for instance
VEGF) were not assessed because protein levels are
expected to change as a response to endurance training
rather than a single exercise bout.
Perspectives
Our findings expose that exercise-induced alterations in
gene transcript and protein expression is partly under the
control, or modulated, by ACE-dependent pathways.
This finding addresses an aspect that has been recog-
nized to be a most potent means of reducing the risk
profile of the cardiovascular patient (Böhm et al., 2008).
Awareness of the existence of such a mechanism could
develop a major impact on current treatment for the
hypertensive patient, which is frequently based on the
inhibition of ACE activity, particularly in the situation of
exercise rehabilitation when one wants to exploit the
sympatholytic and angiogenic benefits of physical
therapy.
Key words: Muscle, exercise, gene, angiotensin,
lisinopril, hypertension, perfusion, hypoxia.
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